Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial

MLA

Claus P. Heussel, et al. “Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial.” Blood, vol. 116, Nov. 2010, p. 2309. EBSCOhost, https://doi.org/10.1182/blood.v116.21.2309.2309.

APA

Claus P. Heussel, Stefan Schwartz, Jorg-Janne Vehreschild, Thomas Lehrnbecher, Andreas H. Groll, Fedja Farowski, Jeremy Franklin, Oliver A. Cornely, Andrew J. Ullmann, Gerda Silling, Meinolf Karthaus, & Maria J. G. T. Rüping. (2010). Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial. Blood, 116, 2309. https://doi.org/10.1182/blood.v116.21.2309.2309

Chicago

Claus P. Heussel, Stefan Schwartz, Jorg-Janne Vehreschild, Thomas Lehrnbecher, Andreas H. Groll, Fedja Farowski, Jeremy Franklin, et al. 2010. “Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial.” Blood 116 (November): 2309. doi:10.1182/blood.v116.21.2309.2309.